We are live on
!
Find out more
Rocket Pharmaceuticals Warrant
RCKTW
RCKTW
17 hedge funds and large institutions have $1.22M invested in Rocket Pharmaceuticals Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
6% more funds holding
Funds holding: 16 → 17 (+1)
0.78% less ownership
Funds ownership: 4.13% → 3.35% (-0.78%)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
77% less capital invested
Capital invested by funds: $5.39M → $1.22M (-$4.17M)
Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$13.5K |
| 2 |
Walleye Capital
New York
|
+$7.18K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$16 |
Top Sellers
| 1 |
CS
Clear Street
New York
|
-$44.1K |
| 2 |
SIM
Sandia Investment Management
Boston,
Massachusetts
|
-$38.6K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$32.1K |
| 4 |
HF
HRT Financial
New York
|
-$6.81K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.41K |
